Affinity Plus™ ASOs for SARS-CoV-2 research

Perfect reagents for knocking down SARS-CoV-2

Our Affinity Plus (LNA) antisense oligonucleotides (ASOs) are perfect reagents for knocking down SARS-CoV-2 for functional assessment or your research dedicated towards the development of potential treatments for COVID-19. We have pre-designed Affinity Plus ASOs targeting different regions of SARS-CoV-2. We also offer custom designs to meet your specific needs.

We are a global leader in antisense oligonucleotide manufacturing, and researchers turn to us for pre-designed or custom antisense oligonucleotides. Here’s why:

  • We are experts in oligonucleotide synthesis and design
  • You can achieve effective inhibition of gene expression in vitro or in vivo with IDT’s Affinity Plus ASOs
  • Our flexible chimeric designs and useful modifications reduce toxicity and artifacts

We know your research is now more urgent than ever, and we’ll prioritize your inquiry. Please complete this short form, and we’ll soon be in touch to discuss your project.